Oncopeptides (ONPPF) Stock Price, News & Analysis

Name: Oncopeptides (ONPPF) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

ONPPF OTC

Company Description

Oncopeptides (OTC: ONPPF) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for ONPPF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

Last updated:

Performance 1 year

Market Cap

Shares outstanding

Latest News

View All

July 29, 2022

0.00%

Number of shares and votes in Oncopeptides

July 20, 2022

0.00%

FDA announces an Oncologic Drugs Advisory Committee meeting to discuss benefit/risk profile of Oncopeptides' Pepaxto

fda approval

January 21, 2022

0.00%

Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US - no intent to market in the US at this time

September 11, 2021

0.00%

Oncopeptides presents phase 3 OCEAN study results at the IMW meeting

clinical trial

May 26, 2021

0.00%

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)

May 5, 2021

0.00%

Oncopeptides completes patient enrollment in phase 2 PORT study

clinical trial

Oncopeptides has 10 recent news articles. Key topics include fda approval, clinical trial. View all ONPPF news →

SEC Filings

View All

No SEC filings available for ONPPF.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ONPPF Company Profile & Sector Positioning

Oncopeptides (ONPPF) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.